Friday 27 May 2022 09:34 PM $9-a-tablet drug used to treat HIV patients could help reverse memory loss trends now

Friday 27 May 2022 09:34 PM $9-a-tablet drug used to treat HIV patients could help reverse memory loss trends now
Friday 27 May 2022 09:34 PM $9-a-tablet drug used to treat HIV patients could help reverse memory loss trends now

Friday 27 May 2022 09:34 PM $9-a-tablet drug used to treat HIV patients could help reverse memory loss trends now

Nine dollar per tablet drug used to treat HIV patients could help reverse memory loss in older age, study finds little tweak to start Scientists at the University of California, Los Angeles, said the drug would be moved to human trials to investigate whether it could strengthen recall The drug works by turning off a gene that makes a protein HIV uses to infect cells This same gene also leads to the deletion of needless memory cells

View
comments

A $9-a-tablet drug used to treat HIV could also help to reverse memory loss in older people, a new study finds.

Scientists at the University of California, Los Angeles (UCLA) found that Maraviroc — sold under the brand name Selzentry — improved memory in middle aged animals.

It will now be moved to human trials to investigate if it can strengthen memory or be an early intervention for dementia patients.

The drug works by turning off a specific gene that makes a cell protein used by HIV to invade them.

But this same gene is also involved in deleting needless memory cells, with studies showing that when it is removed memory is boosted.

More than five million Americans suffer from dementia, estimates suggest, with limited treatments available to slow the diseases symptoms. There is no cure.

A UCLA research team found that Selzentry was able to limit cognitive decline in rats, and are prepared to begin human trials

A UCLA research team found that Selzentry was able to limit cognitive decline in rats, and are prepared to begin human trials

PREV Unvaccinated mother tells of her 'immense guilt' after 21-year-old son was left ... trends now
NEXT UK's prostate cancer revolution: 'Biggest trial in a generation' could lead to ... trends now